EGFR and non-small cell lung carcinoma: The IdyllaTM EGFR Mutation Test may serve as an enabling technology to detect common clinically relevant EGFR variants in NSCLC, either to complement existing workflows permitting a fast-track route, or to establish in-house EGFR-specific initial testing in sites without in-house testing facilities.